EA201791089A1 - Фармацевтические матричные составы, содержащие диметилфумарат - Google Patents

Фармацевтические матричные составы, содержащие диметилфумарат

Info

Publication number
EA201791089A1
EA201791089A1 EA201791089A EA201791089A EA201791089A1 EA 201791089 A1 EA201791089 A1 EA 201791089A1 EA 201791089 A EA201791089 A EA 201791089A EA 201791089 A EA201791089 A EA 201791089A EA 201791089 A1 EA201791089 A1 EA 201791089A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical
dimethylfumarate
pharmaceutical compositions
present
matrixes
Prior art date
Application number
EA201791089A
Other languages
English (en)
Russian (ru)
Inventor
Шиам Б. Карки
Питер Заванех
Чеук-Юи Леунг
Ицин Линь
Original Assignee
Байоджен Ма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байоджен Ма Инк. filed Critical Байоджен Ма Инк.
Publication of EA201791089A1 publication Critical patent/EA201791089A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201791089A 2014-11-19 2015-11-19 Фармацевтические матричные составы, содержащие диметилфумарат EA201791089A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462081907P 2014-11-19 2014-11-19
PCT/US2015/061448 WO2016081671A1 (en) 2014-11-19 2015-11-19 Pharmaceutical matrix formulations comprising dimethyl fumarate

Publications (1)

Publication Number Publication Date
EA201791089A1 true EA201791089A1 (ru) 2017-11-30

Family

ID=54838418

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791089A EA201791089A1 (ru) 2014-11-19 2015-11-19 Фармацевтические матричные составы, содержащие диметилфумарат

Country Status (13)

Country Link
US (2) US20190083404A1 (enExample)
EP (1) EP3220897A1 (enExample)
JP (2) JP6901393B2 (enExample)
KR (1) KR20170086053A (enExample)
CN (2) CN113262205A (enExample)
AU (2) AU2015349891B2 (enExample)
CA (1) CA2967645A1 (enExample)
EA (1) EA201791089A1 (enExample)
HK (1) HK1244215A1 (enExample)
IL (1) IL252105A0 (enExample)
MA (1) MA40990A (enExample)
MX (1) MX391400B (enExample)
WO (1) WO2016081671A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2987895A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
KR102714380B1 (ko) 2021-06-09 2024-10-11 강원대학교산학협력단 경구 투여용 나노입자 및 이의 제조방법
WO2023036702A1 (en) 2021-09-09 2023-03-16 It Pharmagus Limited Method for the manufacturing of a solid body as an oral dosage form of a pharmaceutical or a food supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1207866E (pt) * 1999-08-31 2005-02-28 Gruenenthal Gmbh Forma de administracao retardada contendo sacarinato de tramadol
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
CN109044985A (zh) * 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
NZ617130A (en) * 2009-04-29 2015-06-26 Biogen Ma Inc Treatment of neurodegeneration and neuroinflammation
CA2827990A1 (en) * 2011-02-25 2012-08-30 The Johns Hopkins University Chalcone derivatives as nrf2 activators
US20130158077A1 (en) * 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions
AU2013203445C1 (en) * 2012-02-07 2017-04-20 Biogen Ma Inc. Pharmaceutical compositions containing dimethyl fumarate
AU2013305684B2 (en) * 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
EP3566701A1 (en) * 2012-12-21 2019-11-13 Biogen MA Inc. Deuterium substituted fumarate derivatives
CN105369562B (zh) * 2014-08-28 2019-12-20 青岛海尔洗衣机有限公司 一种带有防衣物褪色提醒功能的洗衣机

Also Published As

Publication number Publication date
AU2021204247A1 (en) 2021-07-22
CA2967645A1 (en) 2016-05-26
MA40990A (fr) 2017-09-26
JP2017534667A (ja) 2017-11-24
MX2017006561A (es) 2018-02-21
MX391400B (es) 2025-03-21
KR20170086053A (ko) 2017-07-25
IL252105A0 (en) 2017-07-31
CN107205942A (zh) 2017-09-26
HK1244215A1 (zh) 2018-08-03
US20190175510A1 (en) 2019-06-13
JP2021152046A (ja) 2021-09-30
CN113262205A (zh) 2021-08-17
US20190083404A1 (en) 2019-03-21
AU2015349891B2 (en) 2021-04-01
JP6901393B2 (ja) 2021-07-14
EP3220897A1 (en) 2017-09-27
AU2015349891A1 (en) 2017-05-25
WO2016081671A1 (en) 2016-05-26
WO2016081671A8 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
MX2022010168A (es) Moduladores de calpainas y usos terapeuticos de los mismos.
MY187540A (en) Compounds active towards bromodomains
PH12019501097A1 (en) Magl inhibitors
MX2017011997A (es) Carbamatos de piperacina y metodos de preparacion y uso.
PH12019501102A1 (en) Magl inhibitors
PH12016501841A1 (en) Immunosuppressant formulation
MX2017004876A (es) Proceso para preparar un eritritol directamente comprimible y usos de este.
EP3604353A4 (en) PHOTOCURING COMPOSITION, BASE FOR DENTAL PROSTHESIS, AND DENTIST
SI3316867T1 (sl) Tablete s takojšnjim sproščanjem, ki vsebujejo zdravilo in postopek za pripravo tablet
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
IL273704A (en) Pharmaceutical bilayer tablet formulations
IN2014MU00916A (enExample)
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
EA201791089A1 (ru) Фармацевтические матричные составы, содержащие диметилфумарат
EP3320908A4 (en) BACTERIAL, ORAL FAST CRUMPING TABLET
IL250419A0 (en) Use of a pill/tablet/capsule of minocycline, plataconazole and atorvastatin in the treatment of multiple sclerosis
DK3453390T3 (da) Farmaceutisk sammensætning indeholdende polymeriseret lægemiddel
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
ZA201901004B (en) High drug loaded tablet composition for treating hiv
DK3153163T3 (da) Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf
MX393741B (es) Comprimido recubierto con pelicula para el tratamiento del dolor agudo.
AP00976S1 (en) Pharmaceutical tablets
AP00975S1 (en) Pharmaceutical tablets
AP00977S1 (en) Pharmaceutical tablets